Coeptis Therapeutics Holdings Inc (COEP)
NASDAQ
The current COEP market cap is 8.48M. The company's latest EPS is USD -0.5172 and P/E is -23.11.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -3.6M | -7.81M | -3.63M | -2.92M | -2.83M |
Net Income | -3.11M | -6.26M | -4.03M | -3M | -3.04M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2k | -68k | -681k | -34.2M | -21.49M |
Net Income | -2k | -67k | 15.23M | -37.57M | -21.27M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 7.16M | 7.17M | 8.07M | 9.39M | 4.2M |
Total Liabilities | 4.67M | 2.16M | 3.76M | 5.04M | 4.51M |
Total Equity | 2.49M | 5.01M | 4.31M | 4.36M | -310k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 172k | 76.71M | 76.17M | 7.92M | 8.07M |
Total Liabilities | 156k | 2.26M | 7.19M | 3.11M | 3.76M |
Total Equity | 16k | 5M | -6.77M | 4.8M | 4.31M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.59M | -5.55M | -7.24M | -1.9M | -3.32M |
Investing | -350k | N/A | N/A | -100k | -100k |
Financing | 3.39M | 3.17M | 4.92M | 1.56M | 3.51M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -2k | -116k | -503k | -3.88M | -7.24M |
Investing | N/A | -75.75M | N/A | N/A | N/A |
Financing | 2k | 76.77M | N/A | 5.49M | 4.92M |
Market Cap | 8.48M |
Price to Earnings Ratio | -23.11 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 334.73 |
Price to Book Ratio | 113.9 |
Dividend Yield | - |
Shares Outstanding | 41.12M |
Average Volume (1 week) | 738.09k |
Average Volume (1 Month) | 1.01M |
52 Week Change | -75.16% |
52 Week High | 0.87 |
52 Week Low | 0.1311 |
Spread (Intraday) | 0 (1.55%) |
Company Name | Coeptis Therapeutics Holdings Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.coeptistx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.